QBiotics reports 80% objective response rate in injected tumours in Stage I of Phase IIA soft tissue sarcoma trial
QBiotics Group Limited (QBiotics) announced final efficacy and safety results from the first stage of…
Browsing: Featured
Improving the efficiency of glioblastoma immunotherapy with gut microbiota
Immunotherapies that activate T cells to eliminate cancer cells have shown limited efficacy as standalone…
Immunotherapy shows promise in aggressive gynaecological clear cell cancers
Australian-led trial delivers encouraging results. A landmark Australian-led phase 2 clinical trial has delivered promising…
Withholding individual patient data: Viewpoint calls for shift in RCT data sharing standards
A new Viewpoint article by Ludovic Trinquart and Martin Stockler, published in JAMA Oncology, is…
Blood test using circulating tumour DNA shows high accuracy for colorectal cancer screening in average-risk populations
A large prospective diagnostic study, published in JAMA, evaluates an investigational blood-based circulating tumor DNA…
Racial differences in tumour collagen structure may impact cancer prognosis
In cancer care, accurate tools for predicting whether a tumour will metastasise can help patients…
Bowel cancer rates are declining in people over 50. But why are they going up in younger adults?
Suzanne Mahady, Monash University Bowel cancer is the fourth most common cancer in Australia, with…
Words matter to people living with cancer. Here’s how verbal microaggressions affect their mental state
Madhu Neupane Bastola, Hong Kong Polytechnic University, and Margo Louise Turnbull, Hong Kong Polytechnic University…
Terahertz polarimetry detects microscopic tissue changes linked to cancer and burns
Recent advances in electronics and optics have opened new possibilities for terahertz (THz) waves—an invisible…
The leading risk factor for cancer isn’t what you think
Kristen Haase, University of British Columbia, and Shabbir Alibhai, University of Toronto If you were…